[go: up one dir, main page]

AU2001266534A1 - Papillomavirus vaccine - Google Patents

Papillomavirus vaccine

Info

Publication number
AU2001266534A1
AU2001266534A1 AU2001266534A AU6653401A AU2001266534A1 AU 2001266534 A1 AU2001266534 A1 AU 2001266534A1 AU 2001266534 A AU2001266534 A AU 2001266534A AU 6653401 A AU6653401 A AU 6653401A AU 2001266534 A1 AU2001266534 A1 AU 2001266534A1
Authority
AU
Australia
Prior art keywords
papillomavirus vaccine
papillomavirus
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001266534A
Inventor
Stefan Schwartz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2001266534A1 publication Critical patent/AU2001266534A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53DNA (RNA) vaccination
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/20011Papillomaviridae
    • C12N2710/20022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/20011Papillomaviridae
    • C12N2710/20034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2001266534A 2000-07-03 2001-06-29 Papillomavirus vaccine Abandoned AU2001266534A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0002498A SE0002498D0 (en) 2000-07-03 2000-07-03 Papillomavirus vaccine
SE0002498 2000-07-03
PCT/SE2001/001501 WO2002002142A1 (en) 2000-07-03 2001-06-29 Papillomavirus vaccine

Publications (1)

Publication Number Publication Date
AU2001266534A1 true AU2001266534A1 (en) 2002-01-14

Family

ID=20280346

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001266534A Abandoned AU2001266534A1 (en) 2000-07-03 2001-06-29 Papillomavirus vaccine

Country Status (3)

Country Link
AU (1) AU2001266534A1 (en)
SE (1) SE0002498D0 (en)
WO (1) WO2002002142A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR200101445T2 (en) 1998-11-27 2001-10-22 Akzo Nobel N.V. Stable, attenuated rabies virus mutants and live vaccines of these mutants
DE102008010954A1 (en) * 2008-02-25 2009-08-27 Cichon, Günter, Prof.Dr. DNA vaccine for the therapy and prophylaxis of cervical cancer and its premalignant precursors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL113817A (en) * 1994-06-30 2001-03-19 Merck & Co Inc Polynucleotide vaccne for papillomavirus

Also Published As

Publication number Publication date
WO2002002142A1 (en) 2002-01-10
WO2002002142B1 (en) 2002-03-21
SE0002498D0 (en) 2000-07-03

Similar Documents

Publication Publication Date Title
AU2002336760A1 (en) Mutable vaccines
SI1410805T1 (en) Vaccine against HPV
AU2002236159A1 (en) Immunogenic complex
AU2001240109A1 (en) Dna vaccines against poxviruses
AU2002254558A1 (en) Novel vaccine
AU2001258279A1 (en) Adjuvant for vaccines
AU2003301850A1 (en) Hiv vaccine
AU5977700A (en) Vaccines
AU1600401A (en) Malaria vaccine
AU2001275723A1 (en) Bougie
AU6158700A (en) Vaccine
AUPR030800A0 (en) Immunomodulatory preparation
AU2002236065A1 (en) Papillomavirus vaccines
AU2002249823A1 (en) Acne vaccine
AU2001267541A1 (en) Vaccine composition
AU2002224845A1 (en) Viral expression system
AU5811600A (en) Vaccine
AU2002222139A1 (en) Hcv vaccines
AU2001266534A1 (en) Papillomavirus vaccine
AU4957800A (en) Vaccine against isa virus
AU2002219846A1 (en) Novel use
AU2000279374A1 (en) Secure syringe
AU2002303093A1 (en) Mycobacterial vaccines
AU5084300A (en) New vaccine formulations - 1
AU2001285421A1 (en) Vaccine against rsv